Breaking News Instant updates and real-time market news.

RHHBY

Roche

$0.00

(0.00%)

, ONCE

Spark Therapeutics

$97.32

0.35 (0.36%)

06:21
09/30/19
09/30
06:21
09/30/19
06:21

Roche again extends Spark Therapeutics tender offer to October 30

Roche (RHHBY) and Spark Therapeutics (ONCE) announced that Roche has extended the offering period of its previously announced tender offer to purchase all of the outstanding shares of common stock of Spark for $114.50 per Share, net to the seller thereof in cash, without interest and subject to any withholding taxes required by applicable law and upon the terms and subject to the conditions set forth in the Offer to Purchase dated March 7, 2019. Pursuant to the Agreement and Plan of Merger, dated as of February 22, 2019, by and among Roche Holdings, Inc., 022019 Merger Subsidiary, Inc., and Spark, the Offer, which was previously scheduled to expire at 5:00 p.m., New York City time, on Tuesday, October 1, 2019, has been extended until 5:00 p.m., New York City time, on Wednesday, October 30, 2019, unless it is extended further under the circumstances set forth in the Merger Agreement. All terms and conditions of the Offer shall remain unchanged during the extended period. The Offer was extended to provide additional time for the U.S. FTC and the UK Competition and Markets Authority to complete their previously disclosed reviews of Roche's pending acquisition of Spark. The parties remain committed to the transaction and are working cooperatively and expeditiously with the FTC and the CMA. Citibank, N.A., the depository for the Offer, has advised Roche that, as of 5:00 p.m., New York City time, on September 27, 2019, approximately 8,251,571 Shares of Spark had been validly tendered and received, and not validly withdrawn, pursuant to the Offer, representing approximately 21.4% of Spark's outstanding Shares.

RHHBY

Roche

$0.00

(0.00%)

ONCE

Spark Therapeutics

$97.32

0.35 (0.36%)

  • 04

    Nov

RHHBY Roche
$0.00

(0.00%)

07/23/19
JPMS
07/23/19
NO CHANGE
JPMS
Neutral
Competition questions for Biogen, Ions' Spinraza not dissipating soon, says JPMorgan
Following Biogen's (BIIB) quarterly results, JPMorgan analyst Jessica Fye notes that while there seems to be limited second quarter impact to the company's and partner Ions Pharmaceuticals' (IONS) Spinraza from Novartis' (NVS) Zolgensma international revenues were down quarter over quarter for a variety of reasons despite double-digit patient growth. Overall, the analyst maintains her view that Roche (RHHBY) and PTC Therapeutics' (PTCT) Risdiplam represents a key potential competitive threat to Spinraza given the convenience of oral dosing and with filing for Risdiplam anticipated in the second half of 2019, in addition to Zolgensma's launch, Fye does not see questions related to competition for Spinraza dissipating anytime soon. The analyst reiterates a Neutral rating on Ions Pharmaceuticals' shares.
07/26/19
UBSW
07/26/19
UPGRADE
UBSW
Buy
Roche upgraded to Buy from Neutral at UBS
UBS analyst Michael Leuchten upgraded Roche to Buy from Neutral and raised his price target for the shares to CHF 300 from CHF 270. The company's legacy portfolio, built around Herceptin and Rituxan, is showing greater resilience while its "credible" neuroscience pipeline is taking shape, Leuchten tells investors in a research note. As such, he now sees Roche's business model as less challenged.
09/13/19
DBAB
09/13/19
NO CHANGE
DBAB
Hold
Novartis' ofatumumab to be 'strong' competitor to Roche drug, says Deutsche Bank
Deutsche Bank analyst Richard Parkes tells investors in a research note after attending the ECTRIMS conference in Stockholm that data from Novartis' (NVS) ASCLEPIOS trials suggests ofatumumab will be a "strong" competitor for Roche's (RHHBY) Ocrevus in relapsing/remitting multiple sclerosis. Parkes says he expects physicians to view the drugs as having broadly comparable and highly compelling efficacy, with ofatumumab's at-home dosing an attractive option for some patients, suggesting meaningful upside potential to his current 2024E ofatumumab sales of $1.1B and possible risks to his forecasts for Roche's Ocrevus. According to physician feedback, Parkes says the drugs are likely to share a rapidly growing market. Parkes maintains a Hold rating and 90 CHF price target on Novartis shares.
09/23/19
GUGG
09/23/19
UPGRADE
Target $403
GUGG
Buy
Guggenheim upgrades Regeneron to Buy, says sentiment too negative
As previously reported, Guggenheim upgraded Regeneron (REGN) to Buy from Neutral as analyst Yatin Suneja noted that Eylea has maintained its dominance in the branded anti-VEGF retinal disease market despite "stiff branded competition" from Roche's (RHHBY) Lucentis and off-label use of Roche's Avastin. Eylea's expansion into new indications has resulted in a diversified business and defensible market position, argued Suneja, who also believes the Street is substantially under-appreciating the market opportunity for Dupixent, which is expected to drive significant leverage in the Sanofi (SNY) antibody collaboration that recently became profitable. Suneja raised the price target on Regeneron shares to $403 from $355.
ONCE Spark Therapeutics
$97.32

0.35 (0.36%)

03/07/19
WBLR
03/07/19
DOWNGRADE
WBLR
Market Perform
William Blair downgrades Spark after filing points to competitive bid process
William Blair analyst Raju Prasad downgraded Spark Therapeutics (ONCE) to Market Perform from Outperform following the filing of its Schedule 14D-9 form that included a summary on the background of the merger agreement with Roche (RHHBY). The filing describes a competitive process that resulted in the final price and furthers the likelihood of the deal closing, Prasad tells investors.
03/25/19
LEHM
03/25/19
DOWNGRADE
Target $115
LEHM
Equal Weight
Spark Therapeutics downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Gena Wang downgraded Spark Therapeutics to Equal Weight from Overweight while raising her price target for the shares to $115 from $74. The analyst cites the pending takeover by Roche (RHHBY) for the downgrade.
05/28/19
FBCO
05/28/19
NO CHANGE
Target $133
FBCO
BioMarin data alleviates valrox durability overhang, re-awakens M&A, says Credit Suisse
Credit Suisse raised its price target for BioMarin (BMRN) to $133 from $131, while nudging up valrox Probability of Success to 75% from 65%. The firm thinks the valoctocogene roxaparvovec data largely alleviates the valrox durability overhang and re-awakens an M&A thesis on BioMarin on the value of its gene therapy platform. The company's de-risked Phase 3 valrox program and established mfg infrastructure put the company's gene tx assets in the valuation range up to that established by the AveXis (AVXS) and Spark Therapeutics (ONCE) transactions, Credit Suisse contends.
06/11/19
JANY
06/11/19
NO CHANGE
JANY
Buy
uniQure weakness a buying opportunity, says Janney Montgomery Scott
Janney Montgomery Scott analyst Yun Zhong said he does not see any fundamental reason for today's weakness in shares of uniQure (QURE), attributing the pullback as likely due to profit taking following some recent strong performance. Roche's (RHHBY) deal to buy Spark Therapeutics (ONCE) in February had a positive impact on the overall gene therapy sector and investor speculation has contributed to an over 30% increase in uniQure shares over the past two weeks, noted Zhong, who said his valuation does not include any acquisition assumption or premium. The analyst, who sees uniQure having the first FDA approval for an AAV gene therapy for hemophilia B and the first AAV gene therapy program in the clinic for Huntington's disease, keeps a Buy rating on the stock and would be a buyer amid today's weakness.

TODAY'S FREE FLY STORIES

TOT

Total

$54.72

-0.08 (-0.15%)

, USO

United States Oil Fund

$11.94

-0.055 (-0.46%)

14:27
11/11/19
11/11
14:27
11/11/19
14:27
Periodicals
Total CEO sees weak oil demand growth next year, Bloomberg says »

Total CEO Patrick…

TOT

Total

$54.72

-0.08 (-0.15%)

USO

United States Oil Fund

$11.94

-0.055 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMB

Kimberly-Clark

$131.12

-0.37 (-0.28%)

, ACN

Accenture

$189.95

0.34 (0.18%)

14:25
11/11/19
11/11
14:25
11/11/19
14:25
Periodicals
Kimberly-Clark moving some ad duties to Accenture from WPP, WSJ says »

Kimberly-Clark (KMB) has…

KMB

Kimberly-Clark

$131.12

-0.37 (-0.28%)

ACN

Accenture

$189.95

0.34 (0.18%)

WPP

WPP

$64.60

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 19

    Nov

  • 19

    Dec

  • 23

    Jan

WPP

WPP

$64.60

-0.01 (-0.02%)

, ACN

Accenture

$190.05

0.44 (0.23%)

14:21
11/11/19
11/11
14:21
11/11/19
14:21
Periodicals
Kimberly-Clark moving some ad duties to Accenture from WPP, WSJ says »

Kimberly-Clark (KMB) has…

WPP

WPP

$64.60

-0.01 (-0.02%)

ACN

Accenture

$190.05

0.44 (0.23%)

KMB

Kimberly-Clark

$131.12

-0.37 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 19

    Nov

  • 19

    Dec

  • 23

    Jan

MS

Morgan Stanley

$49.30

0.15 (0.31%)

14:20
11/11/19
11/11
14:20
11/11/19
14:20
Options
Heavy bullish option flow in Morgan Stanley January term »

Heavy bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 12

    Nov

BABA

Alibaba

$186.42

-0.69 (-0.37%)

, AAPL

Apple

$261.99

1.79 (0.69%)

14:17
11/11/19
11/11
14:17
11/11/19
14:17
Hot Stocks
Alibaba reports 11.11 gross merchandise volume grew 26% year-over-year to $38.4B »

Alibaba Group (BABA)…

BABA

Alibaba

$186.42

-0.69 (-0.37%)

AAPL

Apple

$261.99

1.79 (0.69%)

EL

Estee Lauder

$186.46

-0.81 (-0.43%)

GPS

Gap

$17.01

0.32 (1.92%)

LRLCY

L'Oreal

$0.00

(0.00%)

LEVI

Levi Strauss

$17.07

-0.06 (-0.35%)

NSRGY

Nestle

$0.00

(0.00%)

NKE

Nike

$89.89

0.09 (0.10%)

VFC

VF Corp.

$86.52

-0.56 (-0.64%)

UA

Under Armour

$15.81

-0.07 (-0.44%)

UAA

Under Armour

$17.53

-0.02 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 21

    Nov

  • 06

    Feb

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
11/11/19
11/11
14:17
11/11/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
11/11/19
11/11
14:16
11/11/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$6.05

-0.42 (-6.49%)

14:13
11/11/19
11/11
14:13
11/11/19
14:13
Periodicals
CA governor raises objections to $11B PG&E insurance deal, WSJ reports »

California Governor Gavin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 07

    Jan

AUPH

Aurinia Pharmaceuticals

$5.05

-0.085 (-1.66%)

14:05
11/11/19
11/11
14:05
11/11/19
14:05
Options
Aurinia Pharmaceuticals call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

LPCN

Lipocine

$0.78

-1.945 (-71.38%)

14:04
11/11/19
11/11
14:04
11/11/19
14:04
Recommendations
Lipocine analyst commentary  »

Lipocine price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

$6.93

-0.13 (-1.84%)

13:55
11/11/19
11/11
13:55
11/11/19
13:55
Options
Fitbit put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$7.61

-0.02 (-0.26%)

13:45
11/11/19
11/11
13:45
11/11/19
13:45
Options
Deutsche Bank call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPCN

Lipocine

$0.82

-1.9039 (-69.87%)

13:37
11/11/19
11/11
13:37
11/11/19
13:37
Downgrade
Lipocine rating change  »

Lipocine downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$185.80

-1.31 (-0.70%)

13:35
11/11/19
11/11
13:35
11/11/19
13:35
Recommendations
Alibaba analyst commentary  »

Alibaba Singles Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

S

Sprint

$5.89

-0.22 (-3.60%)

13:35
11/11/19
11/11
13:35
11/11/19
13:35
Options
Sprint put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

GOOG

Alphabet

$1,299.39

-9.97 (-0.76%)

, GOOGL

Alphabet Class A

$1,298.40

-9.58 (-0.73%)

13:34
11/11/19
11/11
13:34
11/11/19
13:34
Periodicals
Google gathering health data on millions of Americans, WSJ reports »

Alphabet's (GOOG,…

GOOG

Alphabet

$1,299.39

-9.97 (-0.76%)

GOOGL

Alphabet Class A

$1,298.40

-9.58 (-0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMK

Weis Markets

$39.40

-0.06 (-0.15%)

, VLGEA

Village Super Market

$26.80

-0.38 (-1.40%)

13:31
11/11/19
11/11
13:31
11/11/19
13:31
Periodicals
Amazon to open grocery store alternative to Whole Foods, CNET says »

CNET's Ben Fox Rubin…

WMK

Weis Markets

$39.40

-0.06 (-0.15%)

VLGEA

Village Super Market

$26.80

-0.38 (-1.40%)

WMT

Walmart

$118.86

-0.55 (-0.46%)

SVU

Supervalu

$0.00

(0.00%)

KR

Kroger

$26.51

-0.5 (-1.85%)

CASY

Casey's General Stores

$166.95

0.07 (0.04%)

AMZN

Amazon.com

$1,770.99

-14.36 (-0.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 19

    Nov

  • 20

    Nov

CDE

Coeur Mining

$6.25

0.305 (5.13%)

13:25
11/11/19
11/11
13:25
11/11/19
13:25
Options
Coeur Mining call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WE

We Company

$0.00

(0.00%)

, JLL

Jones Lang LaSalle

$161.83

0.23 (0.14%)

13:21
11/11/19
11/11
13:21
11/11/19
13:21
Periodicals
We Company outsourcing cleaning staff to JLL, Business Insider reports »

We Company (WE) is…

WE

We Company

$0.00

(0.00%)

JLL

Jones Lang LaSalle

$161.83

0.23 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGM

MGM Resorts

$31.41

0.01 (0.03%)

, DSS

Document Security

$0.34

0.0059 (1.76%)

13:18
11/11/19
11/11
13:18
11/11/19
13:18
On The Fly
Fly Insider: MGM, IDEXX Laboratories among week's notable insider trades »

Welcome to "Fly Insider,"…

MGM

MGM Resorts

$31.41

0.01 (0.03%)

DSS

Document Security

$0.34

0.0059 (1.76%)

CNFR

Conifer Holdings

$4.32

0.42 (10.77%)

OFIX

Orthofix

$44.42

-0.46 (-1.03%)

LMNX

Luminex

$19.33

0.96 (5.23%)

UBER

Uber

$26.93

-0.08 (-0.30%)

REPL

Replimune Group

$16.69

-0.11 (-0.65%)

TPX

Tempur Sealy

$86.40

0.82 (0.96%)

IDXX

Idexx Laboratories

$253.71

-0.8 (-0.31%)

BX

Blackstone

$51.89

0.475 (0.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 19

    Nov

  • 21

    Nov

  • 04

    Dec

  • 09

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
11/11/19
11/11
13:17
11/11/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
11/11/19
11/11
13:16
11/11/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,299.68

-9.68 (-0.74%)

, GOOGL

Alphabet Class A

$1,298.85

-9.13 (-0.70%)

13:13
11/11/19
11/11
13:13
11/11/19
13:13
Hot Stocks
Google says 12 games available on Stadia November 19, including 'Red Dead 2' »

In a blog post, Google…

GOOG

Alphabet

$1,299.68

-9.68 (-0.74%)

GOOGL

Alphabet Class A

$1,298.85

-9.13 (-0.70%)

UBSFY

Ubisoft

$0.00

(0.00%)

T

AT&T

$39.29

-0.08 (-0.20%)

TTWO

Take-Two

$118.69

1.85 (1.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 13

    Nov

  • 18

    Nov

  • 19

    Nov

  • 21

    Nov

  • 09

    Dec

  • 09

    Dec

  • 29

    Jan

TSN

Tyson Foods

$82.88

0.305 (0.37%)

, ROK

Rockwell Automation

$179.88

2.13 (1.20%)

13:05
11/11/19
11/11
13:05
11/11/19
13:05
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

TSN

Tyson Foods

$82.88

0.305 (0.37%)

ROK

Rockwell Automation

$179.88

2.13 (1.20%)

DHI

D.R. Horton

$52.12

1.005 (1.97%)

CBS

CBS

$38.77

0.65 (1.71%)

AAP

Advance Auto Parts

$167.74

0.5 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 18

    Nov

  • 19

    Nov

  • 20

    Nov

  • 09

    Dec

TME

Tencent Music

$14.43

0.44 (3.15%)

, DXC

DXC Technology

$29.61

-0.47 (-1.56%)

13:05
11/11/19
11/11
13:05
11/11/19
13:05
Earnings
Notable companies reporting after market close »

Notable companies…

TME

Tencent Music

$14.43

0.44 (3.15%)

DXC

DXC Technology

$29.61

-0.47 (-1.56%)

TERP

TerraForm Power

$16.57

0.07 (0.42%)

FNV

Franco-Nevada

$95.95

0.34 (0.36%)

UGI

UGI Corporation

$46.23

-0.33 (-0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 11

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.